Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physical exercise training for type 3 spinal muscular atrophy.
Bartels B, Montes J, van der Pol WL, de Groot JF. Bartels B, et al. Among authors: van der pol wl. Cochrane Database Syst Rev. 2019 Mar 1;3(3):CD012120. doi: 10.1002/14651858.CD012120.pub2. Cochrane Database Syst Rev. 2019. PMID: 30821348 Free PMC article. Review.
Drug treatment for spinal muscular atrophy type I.
Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Among authors: van der pol wl, van den berg lh. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006281. doi: 10.1002/14651858.CD006281.pub4. Cochrane Database Syst Rev. 2012. PMID: 22513939 Updated. Review.
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Among authors: van der pol wl, van den berg lh. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006282. doi: 10.1002/14651858.CD006282.pub4. Cochrane Database Syst Rev. 2012. PMID: 22513940 Updated. Review.
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial.
Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C, Lusakowska A, Comi GP, Cuisset JM, Abitbol JL, Scherrer B, Ducray PS, Buchbjerg J, Vianna E, van der Pol WL, Vuillerot C, Blaettler T, Fontoura P; Olesoxime SMA Phase 2 Study Investigators. Bertini E, et al. Among authors: van der pol wl. Lancet Neurol. 2017 Jul;16(7):513-522. doi: 10.1016/S1474-4422(17)30085-6. Epub 2017 Apr 28. Lancet Neurol. 2017. PMID: 28460889 Free article. Clinical Trial.
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman FL, Otto LAM, Goedee HS, Habets LE, de Groot JF, Schoenmakers MAGC, Cuppen I, van den Berg LH, van der Pol WL. Stam M, et al. Among authors: van der pol wl, van den berg lh. BMJ Open. 2018 Jul 30;8(7):e019932. doi: 10.1136/bmjopen-2017-019932. BMJ Open. 2018. PMID: 30061431 Free PMC article.
A continuous repetitive task to detect fatigability in spinal muscular atrophy.
Stam M, Wadman RI, Bartels B, Leeuw M, Westeneng HJ, Wijngaarde CA, van den Berg LH, van der Pol WL. Stam M, et al. Among authors: van der pol wl, van den berg lh. Orphanet J Rare Dis. 2018 Sep 12;13(1):160. doi: 10.1186/s13023-018-0904-5. Orphanet J Rare Dis. 2018. PMID: 30208915 Free PMC article.
218 results